Monday, October 26, 2026
19 C
Bengaluru

First Approach in Pharma

[wpfilebase tag=file id=93 tpl=download-button /]

Inside this Issue

1. Incentivizing a Patient-First Approach in Indian Pharma - interview with Annaswamy Vaidheesh
A conversation with Annaswamy Vaidheesh, Vice President, OPPI, VP, South Asia & Managing Director, India, GSK on GSKs initiatives to meet the demands of Indian pharma in the digital age while putting the patient first

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...

Anuj Pasrija Elevated to Country Lead, J&J MedTech India and Vice President – Surgery

Anuj Pasrija has been elevated to Country Lead, Johnson...

China’s Biopharma Strategy: A Warning and Opportunity for India

China is playing a long game in biopharma. And...

Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences.

With over two decades of experience across finance, strategy,...

Who Is Accountable for the Medicine in Your Hand?

The Accountability Gap: India’s Drug Regulatory System Your doctor prescribes...

Topics

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...

Who Is Accountable for the Medicine in Your Hand?

The Accountability Gap: India’s Drug Regulatory System Your doctor prescribes...

Who Profits From Trust?

Indian healthcare does not suffer from a shortage of...
spot_img

Related Articles

spot_imgspot_img